British Approved Name

International nonproptietary name (INN), Japanese accepted name (fAN), United States adopted name (USAN), and British approved name (BAN). Only selected salts are included. Trade names shown can represent the base or any of the salts included in "Nomenclature". 

Arzncibuch dcr DDR (Pharmacopoeia of the (former) German Democratic Republic), 6 volumes, 1985, British Approved Name... 

B-81MI10608 British Approved Names 1981 , HMSO, London, 1981. 144... 

HAN = British Approved Name s DCF Denomination Commune Franyaise USAN United States Adopted Name 7 CAS Chemical Abstracts Sendee 3- ATC = Anatomic Therapeutic Chemical (Classification of Drugs)... 

Colaspase and crisantaspase are the British Approved Names of asparaginase obtained from cultures of Escherichia coli and Erwinia carotovora respectively. 

Co-dergocrine is the British Approved Name for a formulation that contains a combination of dihydrogenated ergot alkaloids dihydroergocornine mesilate, dihydro-ergocristine mesilate, and (in the ratio 2 1) a- and P-di-hydroergocryptine mesilates. It has been used for its supposed therapeutic effects on mood depression, confusion, and lack of self-care in the elderly, and purportedly acts by improving cerebral blood flow. The basis of these indications has been reviewed and has not been fully validated (1)(2)(3). 

BAN British Approved Name. CNS central nervous system. 

The British Pharmacopoeia Commission was established in 1970 under Section 4 of the Medicines Act 1968. Members of the Commission (approximately 20) are appointed by the Minister of Health and are responsible for preparing new editions of the British Pharmacopoeia (BP) and the British Pharmacopoeia (Veterinary). The Commission also provides members for the UK delegation to meetings of the European Pharmacopoeia committees in Strasbourg and is responsible, under Section 100 of the Medicines Act, for selecting and advising on British Approved Names (BANs). 

BAN (British Approved Names) (The Secretary, British Pharmacopoeia Commission, Market Towers, 1 Nine Ehns Lane, London SW8 5NQ, UK). 

British Approved Names 1986 , British Pharmacopoeia Commission London, Her Majesty s Stationary Office. 

Each chapter has been sub-divided into three sections in the following manner. First, a brief introduction. Second, it follows classification based on either chemical or pharmacological basis. Each category of compound also includes the important representative members of the respective groups together with their International Non-proprietory Names (INN), British Approved Names (BAN) and United States Approved Names (USAN) wherever applicable. Then comes the statement of its chemical name(s), official status in B.P., U.S.P., Eur. P., Int. P., Ind. P., and their proprietory name(s). 

Drugs are usually called by their recommended or proposed International Non-proprietary Names (rINN or pINN) when these are not available, chemical names have been used. If a fixed combination has a generic combination British Approved Name (e.g. co-trimoxazole for trimethoprim -I- sulfamethoxazole) that name has been used in some cases brand names have been used instead. When the plus symbol (-I-) is used to link drug names (for example, lopinavir -I- ritonavir ), it impUes that the two drugs are administered either in one formulation or in conjunction with one another otherwise the word plus is used. 

British Pharmacopoeia Commission, British Approved Names 1990. Her Majesty s Stationary Office, London, 1990, pp. 58 (doxacurium) and 111 (mivacurium). 

---